Salvinorin A: the 'magic mint' hallucinogen finds a molecular target in the kappa opioid receptor

被引:119
作者
Sheffler, DJ
Roth, BL
机构
[1] Case Western Reserve Univ, Sch Med, Natl Inst Mental Hlth, Psychoact Drug Screening Program, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA
关键词
D O I
10.1016/S0165-6147(03)00027-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Salvinorin A, a neoclerodane diterpene, is the most potent naturally occurring hallucinogen known and rivals the synthetic hallucinogen lysergic acid diethylamide in potency. Recently, the molecular target of salvinorin A was identified as the kappa opioid receptor (KOR). Salvinorin A represents the only known non-nitrogenous KOR selective agonist. Based on the selectivity of salvinorin A for the KOR, this receptor represents a potential molecular target for the development of drugs to treat disorders characterized by alterations in perception, including schizophrenia, Alzheimer's disease and bipolar disorder.
引用
收藏
页码:107 / 109
页数:3
相关论文
共 19 条
[1]  
ABRAMOV MM, 1963, J APPL CHEM-USSR, V36, P2471
[2]  
BARD J, 1993, BRAIN RES, V632, P209
[3]   Salvia divinorum:: an hallucinogenic mint which might become a new recreational drug in Switzerland [J].
Giroud, C ;
Felber, F ;
Augsburger, M ;
Horisberger, B ;
Rivier, L ;
Mangin, P .
FORENSIC SCIENCE INTERNATIONAL, 2000, 112 (2-3) :143-150
[4]   THE ABSOLUTE STEREOCHEMISTRY OF SALVINORINS [J].
KOREEDA, M ;
BROWN, L ;
VALDES, LJ .
CHEMISTRY LETTERS, 1990, (11) :2015-2018
[5]   The therapeutic role of naltrexone in negative symptom schizophrenia [J].
Marchesi, GF ;
Santone, G ;
Cotani, P ;
Giordano, A ;
Chelli, F .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1995, 19 (08) :1239-1249
[6]   μ-, δ- and κ-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients [J].
Mathieu-Kia, AM ;
Fan, LQ ;
Kreek, MJ ;
Simon, EJ ;
Hiller, JM .
BRAIN RESEARCH, 2001, 893 (1-2) :121-134
[7]   OPIOID PEPTIDE RECEPTOR STUDIES .3. INTERACTION OF OPIOID-PEPTIDES AND OTHER DRUGS WITH 4 SUBTYPES OF THE KAPPA(2) RECEPTOR IN GUINEA-PIG BRAIN [J].
NI, Q ;
XU, H ;
PARTILLA, JS ;
DECOSTA, BR ;
RICE, KC ;
KAYAKIRI, H ;
ROTHMAN, RB .
PEPTIDES, 1995, 16 (06) :1083-1095
[8]   SALVINORIN, A NEW TRANS-NEOCLERODANE DITERPENE FROM SALVIA-DIVINORUM (LABIATAE) [J].
ORTEGA, A ;
BLOUNT, JF ;
MANCHAND, PS .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1982, (10) :2505-2508
[9]   PSYCHOTOMIMESIS MEDIATED BY KAPPA-OPIATE RECEPTORS [J].
PFEIFFER, A ;
BRANTL, V ;
HERZ, A ;
EMRICH, HM .
SCIENCE, 1986, 233 (4765) :774-776
[10]   Activation is hallucinogenic and antagonism is therapeutic:: Role of 5-HT2A receptors in atypical antipsychotic drug actions [J].
Roth, BL ;
Willins, DL ;
Kristiansen, K ;
Kroeze, WK .
NEUROSCIENTIST, 1999, 5 (04) :254-262